期刊文献+

尿毒症患者血液透析治疗对瘦素和神经肽Y水平的影响 被引量:1

The Effect of Hemodialysis on the Levels of Plasma Leptin and Serum Neuropeptide Y in Uremia Patients
下载PDF
导出
摘要 研究尿毒症患者血液透析前后血浆瘦素和血清神经肽Y(NPY)的变化,探讨改善尿毒症营养不良的有效措施。本文尿毒症患者69例,分为3组:低通量纤维素膜透析组(A组)32例,低通量血仿膜F6透析组(B组)21例,F60高通量血滤器透析滤过并血液透析组(C组)16例。对照组18名。用RIA测定患者透析前、后及对照组血浆瘦素及血清NPY水平。结果三组瘦素与NPY水平透析前明显高于对照组(P<0.01);透析后A、B组瘦素、NPY水平未降低,C组瘦素水平明显降低(P<0.05),但NPY无显著变化。尿毒症患者存在高瘦素及NPY血症,二者无相关性,都不能通过单纯血液透析清除。利用高通量血滤器进行血液滤过有助于增加瘦素的清除率,改善患者营养状态。 To evaluate the changes of plasma leptin and serum neuropeptide Y (NPY) levels in uremia patients after hemodialysis and to discuss the efficient method on improving uremia malnutrition. 69 uremia patients were divided into 3 groups: Group A with 32 patients using low- flux cellulosic dialyzer, Group B with 21 patients using low-flux polysulfone dialyzer(F6), and Group C with 16 patients using high-flux polysulfone dialyzer (F60) and blood dialyzer. 18 healthy volunteers were chosen as the control group. The plasma leptin and serum NPY levels were detected by RIA in uremia patients before and after dialysis and in control group. Compared with control, all uremia patients had obviously higher leptin and NPY levels before dialysis (P〈0.01) ; Leptin and NPY levels in group A and B did not change after dialysis. The leptin levels were significantly decreased in group C after dialysis (P〈0.05), but NPY levels did not change. There was no correlation between higher levels of leptin and NPY in uremia patients. They could not be cleared by hemodialysis alone. Hemo-filtration with high flux polysulfone dialyzer could increase the clearance efficiency of leptin and improve nutritional conditions for uremia patients.
出处 《标记免疫分析与临床》 CAS 2007年第1期10-11,21,共3页 Labeled Immunoassays and Clinical Medicine
关键词 血液透析 尿毒症 放射免疫分析 瘦素 神经肽Y Hemodialysis Uremia RIA Leptin Neuropeptide Y
  • 相关文献

参考文献4

二级参考文献16

  • 1肖创清,何云南.血清瘦素放射免疫分析的临床应用进展(文献综述)[J].放射免疫学杂志,2005,18(5):383-385. 被引量:6
  • 2高连如,赵云涛,朱智明,栾佐,石湘芸,熊鉴然,杨晔,田青,张肇康,唐朝枢.肥胖基因表达产物与肥胖的关系[J].中华内科杂志,1997,36(3):180-182. 被引量:6
  • 3Zhang Y,Poenca R,Maffei M,et al.Positional cloning of the mouse obese gene and its human homologue.Nature.1994,372:425.
  • 4Halaas JL,Gajiwala KS,Maffei M,et al.Weight-reducing effects of the plasma protein encoded by the obese gene.Science.1995,269:543.
  • 5Cohen B,Novik D,Rubinstein M,et al.Modulation of insulin activites by leptin.Science.1996,274:1.
  • 6Merabet E,Dagogo-Jack S,Coyne DW,et al.Increased plasma leptin concentration in end-stage renal disease.J Clin Endocrinal Metab.1997,82:847.
  • 7Kolaczynski JW,Nyce MR,Considine RV,et al.Acute and chronic effect of insulin on leptin production in humans:studies in vivo and in vitro.Diabetes.1996,45:699.
  • 8Shek EW,Brands MW,Hall JE.Chronic leptin infusion increases arterial pressure.Hypertension.1998,31:409.
  • 9Lord GM Matarese G,Howard JK,et al.Leptin modulates the T-cell immune response and reverses starvation induced immunosuppression.Nature.1998,349:897.
  • 10Sharma K,Considine RV,Michael B,et al.Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients.Kidney Int.1997,51:1980.

共引文献10

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部